Home/Filings/4/0001171843-17-005464
4//SEC Filing

Meyenburg Jason Patrick 4

Accession 0001171843-17-005464

CIK 0001365216other

Filed

Sep 7, 8:00 PM ET

Accepted

Sep 8, 4:40 PM ET

Size

4.5 KB

Accession

0001171843-17-005464

Insider Transaction Report

Form 4
Period: 2017-09-06
Meyenburg Jason Patrick
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock, Class A

    2017-09-06$12.13/sh+4,000$48,50030,228 total

Issuer

Sucampo Pharmaceuticals, Inc.

CIK 0001365216

Entity typeother

Related Parties

1
  • filerCIK 0001709008

Filing Metadata

Form type
4
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 4:40 PM ET
Size
4.5 KB